Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Moderna Refused China Request to Reveal Vaccine Technology

News

Moderna Refused China Request to Reveal Vaccine Technology

-FT https://www.ft.com/content/a481c129-c5aa-4972-84a8-3a45bb000098

byCharles Gross

October 1, 2022

1 minute read

-FT

https://www.ft.com/content/a481c129-c5aa-4972-84a8-3a45bb000098

Barclays Maintains Overweight on Workday, Raises Price Target to $203

By Benzinga Newsdesk

November 30, 7:13 AM

Barclays analyst Raimo Lenschow maintains Workday (NASDAQ:WDAY) with a Overweight and raises the price target from $198 to $203.

WDAY

Jim Cramer Recommends Holding This Health Care Stock: ‘Re-Inventing Itself, Doing A Terrific Job’

By Priya Nigam

July 27, 11:01 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Tri Pointe Homes, Inc. (NYSE: TPH) is "still good.

CAKE

COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And ‘Strong Progress Across The Business’

By Lara Goldstein

August 3, 4:21 PM

Psychedelics biotech COMPASS Pathways’ (NASDAQ: CMPS) consolidated unaudited financial results for the second quarter 2023, ended June 30 are as follows:

CMPS

Repo Rates Spike: Are Lessons Of The 2019 Funding Crisis Being Heeded?

By Neil Dennis

December 5, 1:47 PM

The U.S. repo market is experiencing stress due to rising short-term interest rates, reminiscent of the 2019 funding crisis.

FLOT

Moderna Refused China Request to Reveal Vaccine Technology

Related Posts

Barclays Maintains Overweight on Workday, Raises Price Target to $203

Jim Cramer Recommends Holding This Health Care Stock: ‘Re-Inventing Itself, Doing A Terrific Job’

COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And ‘Strong Progress Across The Business’

Repo Rates Spike: Are Lessons Of The 2019 Funding Crisis Being Heeded?